- Home
- SRTS vs CVM Comparison
SRTS vs CVM Comparison
Compare SRTS & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRTS
- CVM
- Stock Information
- Founded
- SRTS 2010
- CVM 1983
- Country
- SRTS United States
- CVM United States
- Employees
- SRTS N/A
- CVM N/A
- Industry
- SRTS Medical/Dental Instruments
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SRTS Health Care
- CVM Health Care
- Exchange
- SRTS Nasdaq
- CVM Nasdaq
- Market Cap
- SRTS 52.9M
- CVM 53.1M
- IPO Year
- SRTS 2016
- CVM 1987
- Fundamental
- Price
- SRTS $4.24
- CVM $7.05
- Analyst Decision
- SRTS Strong Buy
- CVM
- Analyst Count
- SRTS 3
- CVM 0
- Target Price
- SRTS $8.00
- CVM N/A
- AVG Volume (30 Days)
- SRTS 143.2K
- CVM 95.9K
- Earning Date
- SRTS 11-06-2025
- CVM 08-14-2025
- Dividend Yield
- SRTS N/A
- CVM N/A
- EPS Growth
- SRTS N/A
- CVM N/A
- EPS
- SRTS N/A
- CVM N/A
- Revenue
- SRTS $35,609,000.00
- CVM N/A
- Revenue This Year
- SRTS N/A
- CVM N/A
- Revenue Next Year
- SRTS $47.33
- CVM N/A
- P/E Ratio
- SRTS N/A
- CVM N/A
- Revenue Growth
- SRTS N/A
- CVM N/A
- 52 Week Low
- SRTS $3.03
- CVM $1.98
- 52 Week High
- SRTS $9.33
- CVM $32.70
- Technical
- Relative Strength Index (RSI)
- SRTS 70.02
- CVM 37.75
- Support Level
- SRTS $3.07
- CVM $6.86
- Resistance Level
- SRTS $4.19
- CVM $7.44
- Average True Range (ATR)
- SRTS 0.29
- CVM 0.67
- MACD
- SRTS 0.08
- CVM -0.18
- Stochastic Oscillator
- SRTS 100.00
- CVM 30.07
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.